| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/06/2013 | EP2564900A1 C-19 steroids for therapeutic uses |
| 03/06/2013 | EP2564874A1 Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof |
| 03/06/2013 | EP2564867A1 Autologous biological cancer vaccine |
| 03/06/2013 | EP2564866A2 Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | EP2564852A1 Anti-brain-tumor drug |
| 03/06/2013 | EP2564846A1 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with anti-cd20 agents |
| 03/06/2013 | EP2564845A1 Diindolylmethane-based drug for the treatment of hyperplastic and inflammatory diseases |
| 03/06/2013 | EP2563922A1 Nucleic acid compounds with conformationally restricted monomers and uses thereof |
| 03/06/2013 | EP2563919A1 Tumor-specific promoter and oncolytic virus vector comprising the same |
| 03/06/2013 | EP2563803A1 Anticancer steroidal lactones unsaturated in position 7 (8) |
| 03/06/2013 | EP2563801A2 Substitution derivatives of n6-benzyladenosine-5´-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparation containing these compounds |
| 03/06/2013 | EP2563795A1 Inhibitors of protein tyrosine kinase activity |
| 03/06/2013 | EP2563792A1 Imidazopyridazinyl compounds and their uses for cancer |
| 03/06/2013 | EP2563788A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases |
| 03/06/2013 | EP2563785A1 Compounds as agonists of s1p1 receptors |
| 03/06/2013 | EP2563777A2 Inverse agonists and neutral antagonists for the tsh receptor |
| 03/06/2013 | EP2563775A1 Pyrazolyl quinazoline kinase inhibitors |
| 03/06/2013 | EP2563774A1 Pyrimidinyl indole compounds |
| 03/06/2013 | EP2563773A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activites |
| 03/06/2013 | EP2563771A2 Metalloenzyme inhibitor compounds |
| 03/06/2013 | EP2563763A1 Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
| 03/06/2013 | EP2563761A1 Activators of human pyruvate kinase |
| 03/06/2013 | EP2563405A1 Selective integrin inhibitors |
| 03/06/2013 | EP2563400A1 Modified binding proteins inhibiting the vegf-a receptor interaction |
| 03/06/2013 | EP2563398A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 03/06/2013 | EP2563392A1 Detection and modulation of slit and roundabount (robo) mediated lymph vessel formation and uses thereof |
| 03/06/2013 | EP2563384A2 Immunogenic compositions and methods for treating neoplasia |
| 03/06/2013 | EP2563383A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| 03/06/2013 | EP2563382A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases |
| 03/06/2013 | EP2563381A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases |
| 03/06/2013 | EP2563380A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
| 03/06/2013 | EP2563368A1 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
| 03/06/2013 | EP2563362A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites |
| 03/06/2013 | EP2563360A2 Biomarkers for mdm2 inhibitors for use in treating disease |
| 03/06/2013 | EP2563358A1 Inhibitors of phosphoinositide dependent kinase 1 (pdk1) |
| 03/06/2013 | EP1718283B1 Topical co-enzyme q10 formulations and methods of use |
| 03/06/2013 | CN202761744U Traditional Chinese medicine patch |
| 03/06/2013 | CN1856469B Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 03/06/2013 | CN102958942A Heterodimer binding proteins and uses thereof |
| 03/06/2013 | CN102958941A Compositions and methods for the diagnosis and treatment of tumor |
| 03/06/2013 | CN102958937A Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 03/06/2013 | CN102958930A 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 03/06/2013 | CN102958928A Dimeric SMAC Mimetics |
| 03/06/2013 | CN102958927A Indazole inhibitors of kinase |
| 03/06/2013 | CN102958925A Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer |
| 03/06/2013 | CN102958919A Novel tetrahydroquinoline derivatives |
| 03/06/2013 | CN102958917A Compositions and methods for modulating the wnt signaling pathway |
| 03/06/2013 | CN102958532A Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | CN102958530A Blockade of CCL18 signaling via CCR6 as therapeutic option in fibrotic diseases and cancer |
| 03/06/2013 | CN102958527A Anti-cancer composition comprising alginate |
| 03/06/2013 | CN102958523A Antitumor agent using compounds having kinase inhibitory effect in combination |
| 03/06/2013 | CN102958518A Combination of a phosphoinositide 3-kinase inhibitor and an antidiabetic compound for use in the treatment of proliferative diseases |
| 03/06/2013 | CN102952849A Application of protein coded by gene LIMG and antibody thereof in breast cancer diagnosis and/or treatment |
| 03/06/2013 | CN102952799A Applications of gene and protein coded thereby to promotion of cell cytoplasm cleavage and cell proliferation as well as research and development of drugs |
| 03/06/2013 | CN102952783A Newcastle disease virus NDV PY strain and application thereof |
| 03/06/2013 | CN102952756A Marine fungi altemaria MNP801 and application thereof |
| 03/06/2013 | CN102952739A Health care medicinal liquor |
| 03/06/2013 | CN102952207A Preparation method and application of 6-(1-methyl-beta-carboline-3-carboxylic acetyl)-6-deoxy-beta-cyclodextrin and supramolecular inclusion complex thereof with adriamycin |
| 03/06/2013 | CN102952191A Fully human CD33 single-chain antibody ZJL101 and applications thereof |
| 03/06/2013 | CN102952190A Microbubble membrane protein and application thereof |
| 03/06/2013 | CN102952184A Application of antineoplastic activity protein TB-1 in preparation of antineoplastic drugs |
| 03/06/2013 | CN102952168A Estrogen derivative used as vasoinhibitor, as well as preparation method and medical application thereof |
| 03/06/2013 | CN102952151A 3-position bis-beta-carboline alkali compound, and preparation method, pharmaceutical composition and application thereof |
| 03/06/2013 | CN102952134A Difluoromethyl-containing cytisine derivative, preparation method and antitumous effect research |
| 03/06/2013 | CN102952129A Tetrahydropyridodihydropyrimidinone derivative, its preparation method and application |
| 03/06/2013 | CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof |
| 03/06/2013 | CN102952104A Furan compound |
| 03/06/2013 | CN102952076A Preparation of pyrazoline compound and application of pyrazoline compound in anticancer treatment |
| 03/06/2013 | CN102952062A Substituted benzoheterocyclic compounds and preparation method and application thereof |
| 03/06/2013 | CN102949732A Medicine fusion specifically bound with human angiopoietin-2 |
| 03/06/2013 | CN102949729A Active targeting type small interfering ribonucleic acid (siRNA) delivery carrier and preparation method thereof |
| 03/06/2013 | CN102949728A Meso-porous silicon nano-drug carrier with both reduction responsiveness and targeting ability and preparation method thereof |
| 03/06/2013 | CN102949727A Common carrier material for targeting anticancer drug and gene and preparation and application |
| 03/06/2013 | CN102949712A Chinese and western composite medicine for treating neoplastic diseases |
| 03/06/2013 | CN102949696A Medicine for treating cancer and preparation method thereof |
| 03/06/2013 | CN102949687A Oral medicine for treating tumors and production method thereof |
| 03/06/2013 | CN102949679A Medicine for curing lung cancer and preparation method thereof |
| 03/06/2013 | CN102949649A Traditional Chinese medicine prescription for treating heart disease |
| 03/06/2013 | CN102949635A Health-care product capsule for myoma of uterus and preparation method thereof |
| 03/06/2013 | CN102949610A Production process of highland barley Fermentum Rubrum with high tocol content |
| 03/06/2013 | CN102949440A Licoflavone phospholipid complex and preparation method and application thereof |
| 03/06/2013 | CN102949438A Licorice root extract and preparation method thereof |
| 03/06/2013 | CN102949436A Externally-used medicinal liquor for treating body surface negative tumor |
| 03/06/2013 | CN102949421A In-vitro antitumor effect of nanocrystallized ginseng |
| 03/06/2013 | CN102949415A Propolis fat emulsion preparation and preparation method thereof |
| 03/06/2013 | CN102949414A Medicament for treating breast cancer, and preparation method thereof |
| 03/06/2013 | CN102949412A Powder for treating body surface positive tumor |
| 03/06/2013 | CN102949399A Application of tanshinone IIA in preparation of medicines inhibiting keratinocyte proliferation diseases |
| 03/06/2013 | CN102949394A Application of 4-[6-(4-isopropoxypheny) pyrazolo [1, 5-a] pyrimidin-3-yl] quinoline to preparation of autophagy inhibitor or tumor sensitizing drug |
| 03/06/2013 | CN102949388A Isoflavones composition and medicine made of same |
| 03/06/2013 | CN102949386A Medical application of prze-watanshinquinone B |
| 03/06/2013 | CN102949385A Yew branch and leaf extract, extraction method and applications thereof |
| 03/06/2013 | CN102949384A Application of coffee acid 3, 4-dihydroxy benzene ethyl ester to preparation of antitumor drug |
| 03/06/2013 | CN102949363A Ursolic acid liquid-solid compression tablet |
| 03/06/2013 | CN102949353A oxaliplatin lyophilized pharmaceutical composition for injection and |
| 03/06/2013 | CN102949352A Decitabine freeze-dried powder injection and preparation method thereof |
| 03/06/2013 | CN102949351A Preparation method of temozolomide lyophilized preparation |
| 03/06/2013 | CN102949350A Lyophilized preparation of temozolomide and its preparation method |
| 03/06/2013 | CN102949347A Docetaxel-coated polylactic-co-glycolic acid (PLGA) nano particles and preparation method thereof |
| 03/06/2013 | CN102949346A Protein medicine-carrying nano particle synthesis method |